13th April 2025, A/Prof Chee L Khoo
Continuous glucose monitoring (CGM) was first shown to be beneficial in the management of patients with type 1 diabetes. Later on, patients with type 2 diabetes on insulin also found CGM beneficial in more ways than one. Of course, patients with T2D not on insulin also found CGM beneficial. What else can we use CGM for?…
12th April 2025, NIA Diagnostic Imaging
Uterine fibroids, also referred to as leiomyomas, are the most prevalent benign tumors in women of reproductive age, originating from smooth muscle cells in the uterus (myometrium) (1). While benign, uterine fibroids can greatly affect a woman’s daily quality of life (4). Ultrasound is the first-line modality used for diagnosing and characterising these fibroids (5).…
14th March 2025, NIA Diagnostic Imaging
Plantar Fasciitis is the most common cause of heel pain in adults affecting about 10% of the adult population. It is most common in women aged between 40-60 years. It stems from the degenerative irritation of the plantar fascia origin at the medial calcaneal tuberosity of the heel and its surrounding perifascial structures.…
10th February 2025, A/Prof Chee L Khoo
We perform cardiovascular (CV) risk assessments in our consulting rooms everyday. We assess lipid profiles, smoking history, family history and activity levels in our patients routinely and try to quantify the likelihood they may have a cardiovascular event. Over the years at GPVoice we have tried to expand beyond the traditional risk factors as more data come to hand.…
A/Prof Chee L Khoo, 26th January 2025
Obesity was first recognised as a disease by WHO in 1948, and more recently also by several medical societies and countries (1–9). The current WHO International Classification of Disease labels obesity as “a chronic complex disease”. But obesity is a highly heterogenous condition and many people with excess adiposity have no signs of illness.…
A/Prof Chee L Khoo, 23rd January 2025
We explored the benefits (or lack of) of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) back in early December 2024 when we look at the indications and criteria to initiate icosapent ethyl in patients with residual hypertriglyceridaemia for cardiovascular benefit. Now, omega-3 fatty acid (O3FA) supplements often contain a combination of EPA and DHA.…
14th January 2025, NIA Diagnostic Imaging
It is usually not difficult to diagnose osteoporosis once a patient has fractured a bone or two. The key in primary care is to try to diagnose those at risk of osteoporosis and prevent a fracture, especially neck of femur fracture. The consequence of a neck of femur fracture is quite significant especially in elder patients.…
8th January 2025, A/Prof Chee L Khoo
Obstructive sleep apnoea (OSA) often (but not always) lead to daytime sleepiness and suboptimal daytime performance (including driving performance). It can also have a major effect on the quality of life (QOL) of the patient and the family. OSA is associated with a number important metabolic and cardiovascular conditions in a multidirectional manner.…
23rd December 2024, A/Prof Chee L Khoo
Is this one of those “adverse events” related to the GLP1 agonist your patient saw on google one day? I can see you roll your eyes and I thought that way too initially. But upon further research, it seems to be a real thing as there was a study published in the JAMA Ophthalmology recently.…
12th December 2024, A/Prof Chee L Khoo
Back in August this year, when we last highlighted the benefits of the new pure eicosapentaenoic acid (EPA), icosapent ethyl (Vazkepa®), in reducing cardiovascular outcomes in patients with high triglycerides and high cardiovascular risk, we foreshadowed that it will be available on the PBS for patients with established cardiovascular disease. It is now on PBS Authority and there isn’t much of a launch of the drug which is a pity as many of our patients who may benefit from icosapent ethyl who should be on it aren’t because most of us (including me) are still confused as to who will benefit and who is eligible.…
12th December, NIA Diagnostic Imaging
We know that screening mammography is not perfect. This is particularly the case in breasts that are dense. Breast tissue density is a predictor of breast cancer (BC) risk (1-3). Pooled analyses have shown a fourfold to fivefold increase in BC risk for women with the highest breast tissue density compared with those classified in the lowest density category, independently of other risk factors for BC that may be present in women with high breast density (1,3).…
29th November 2024, A/Prof Chee L Khoo
We have written a bit on the paradigm change in our diagnosis and management of GDM over the last couple of years. We have looked at the TOBOGM study at length about early GDM (eGDM). This is GDM diagnosed before 24-week gestation. The TOBOGM study demonstrated that it is important to diagnosed early GDM as early treatment significantly improve neonatal and maternal outcomes.…